Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 43 entries
Sorted by: Best Match Show Resources per page
Erratum to: Unraveling the associations of age and menopause with cardiovascular risk factors in a large population-based study.

BMC medicine

de Kat AC, Dam V, Onland-Moret NC, Eijkemans MJ, Broekmans FJ, van der Schouw YT.
PMID: 28356103
BMC Med. 2017 Mar 29;15(1):74. doi: 10.1186/s12916-017-0841-5.

No abstract available.

Cite
de Kat AC, Dam V, Onland-Moret NC, et al. Erratum to: Unraveling the associations of age and menopause with cardiovascular risk factors in a large population-based study. BMC Med. 2017;15(1):74doi: 10.1186/s12916-017-0841-5.
de Kat, A. C., Dam, V., Onland-Moret, N. C., Eijkemans, M. J., Broekmans, F. J., & van der Schouw, Y. T. (2017). Erratum to: Unraveling the associations of age and menopause with cardiovascular risk factors in a large population-based study. BMC medicine, 15(1), 74. https://doi.org/10.1186/s12916-017-0841-5
de Kat, A C, et al. "Erratum to: Unraveling the associations of age and menopause with cardiovascular risk factors in a large population-based study." BMC medicine vol. 15,1 (2017): 74. doi: https://doi.org/10.1186/s12916-017-0841-5
de Kat AC, Dam V, Onland-Moret NC, Eijkemans MJ, Broekmans FJ, van der Schouw YT. Erratum to: Unraveling the associations of age and menopause with cardiovascular risk factors in a large population-based study. BMC Med. 2017 Mar 29;15(1):74. doi: 10.1186/s12916-017-0841-5. PMID: 28356103; PMCID: PMC5372294.
Copy Download .nbib Format: NLM
Diversity within Serogroups of Rhizobium leguminosarum biovar viceae in the Palouse Region of Eastern Washington as Indicated by Plasmid Profiles, Intrinsic Antibiotic Resistance, and Topography.

Applied and environmental microbiology

Brockman FJ, Bezdicek DF.
PMID: 16347814
Appl Environ Microbiol. 1989 Jan;55(1):109-15. doi: 10.1128/aem.55.1.109-115.1989.

Serology, plasmid profiles, and intrinsic antibiotic resistance (IAR) were determined for 192 isolates of Rhizobium leguminosarum biovar viceae from nodules of peas (Pisum sativum L.) grown on the south slope and bottomland topographic positions in eastern Washington State. A...

Cite
Brockman FJ, Bezdicek DF. Diversity within Serogroups of Rhizobium leguminosarum biovar viceae in the Palouse Region of Eastern Washington as Indicated by Plasmid Profiles, Intrinsic Antibiotic Resistance, and Topography. Appl Environ Microbiol. 1989;55(1):109-15doi: 10.1128/aem.55.1.109-115.1989.
Brockman, F. J., & Bezdicek, D. F. (1989). Diversity within Serogroups of Rhizobium leguminosarum biovar viceae in the Palouse Region of Eastern Washington as Indicated by Plasmid Profiles, Intrinsic Antibiotic Resistance, and Topography. Applied and environmental microbiology, 55(1), 109-15. https://doi.org/10.1128/aem.55.1.109-115.1989
Brockman, F J, and Bezdicek, D F. "Diversity within Serogroups of Rhizobium leguminosarum biovar viceae in the Palouse Region of Eastern Washington as Indicated by Plasmid Profiles, Intrinsic Antibiotic Resistance, and Topography." Applied and environmental microbiology vol. 55,1 (1989): 109-15. doi: https://doi.org/10.1128/aem.55.1.109-115.1989
Brockman FJ, Bezdicek DF. Diversity within Serogroups of Rhizobium leguminosarum biovar viceae in the Palouse Region of Eastern Washington as Indicated by Plasmid Profiles, Intrinsic Antibiotic Resistance, and Topography. Appl Environ Microbiol. 1989 Jan;55(1):109-15. doi: 10.1128/aem.55.1.109-115.1989. PMID: 16347814; PMCID: PMC184063.
Copy Download .nbib Format: NLM
Isolation and characterization of a subsurface bacterium capable of growth on toluene, naphthalene, and other aromatic compounds.

Applied and environmental microbiology

Fredrickson JK, Brockman FJ, Workman DJ, Li SW, Stevens TO.
PMID: 16348445
Appl Environ Microbiol. 1991 Mar;57(3):796-803. doi: 10.1128/aem.57.3.796-803.1991.

A bacterium, designated F199, utilized toluene, naphthalene, dibenzothiophene, salicylate, benzoate, p-cresol, and all isomers of xylene as a sole carbon and energy source. This bacterium was isolated from Middendorf sediments, a Cretaceous age formation that underlies the Southeast Coastal...

Cite
Fredrickson JK, Brockman FJ, Workman DJ, et al. Isolation and characterization of a subsurface bacterium capable of growth on toluene, naphthalene, and other aromatic compounds. Appl Environ Microbiol. 1991;57(3):796-803doi: 10.1128/aem.57.3.796-803.1991.
Fredrickson, J. K., Brockman, F. J., Workman, D. J., Li, S. W., & Stevens, T. O. (1991). Isolation and characterization of a subsurface bacterium capable of growth on toluene, naphthalene, and other aromatic compounds. Applied and environmental microbiology, 57(3), 796-803. https://doi.org/10.1128/aem.57.3.796-803.1991
Fredrickson, J K, et al. "Isolation and characterization of a subsurface bacterium capable of growth on toluene, naphthalene, and other aromatic compounds." Applied and environmental microbiology vol. 57,3 (1991): 796-803. doi: https://doi.org/10.1128/aem.57.3.796-803.1991
Fredrickson JK, Brockman FJ, Workman DJ, Li SW, Stevens TO. Isolation and characterization of a subsurface bacterium capable of growth on toluene, naphthalene, and other aromatic compounds. Appl Environ Microbiol. 1991 Mar;57(3):796-803. doi: 10.1128/aem.57.3.796-803.1991. PMID: 16348445; PMCID: PMC182797.
Copy Download .nbib Format: NLM
Phenotypic characterization of patients with deletions in the 3'-flanking SHOX region.

PeerJ

Kant SG, Broekman SJ, de Wit CC, Bos M, Scheltinga SA, Bakker E, Oostdijk W, van der Kamp HJ, van Zwet EW, van der Hout AH, Wit JM, Losekoot M.
PMID: 23638371
PeerJ. 2013 Feb 19;1:e35. doi: 10.7717/peerj.35. Print 2013.

Context. Leri-Weill dyschondrosteosis is a clinically variable skeletal dysplasia, caused by SHOX deletion or mutations, or a deletion of enhancer sequences in the 3'-flanking region. Recently, a 47.5 kb recurrent PAR1 deletion downstream of SHOX was reported, but its...

Cite
Kant SG, Broekman SJ, de Wit CC, et al. Phenotypic characterization of patients with deletions in the 3'-flanking SHOX region. PeerJ. 2013;1:e35doi: 10.7717/peerj.35.
Kant, S. G., Broekman, S. J., de Wit, C. C., Bos, M., Scheltinga, S. A., Bakker, E., Oostdijk, W., van der Kamp, H. J., van Zwet, E. W., van der Hout, A. H., Wit, J. M., & Losekoot, M. (2013). Phenotypic characterization of patients with deletions in the 3'-flanking SHOX region. PeerJ, 1e35. https://doi.org/10.7717/peerj.35
Kant, Sarina G, et al. "Phenotypic characterization of patients with deletions in the 3'-flanking SHOX region." PeerJ vol. 1 (2013): e35. doi: https://doi.org/10.7717/peerj.35
Kant SG, Broekman SJ, de Wit CC, Bos M, Scheltinga SA, Bakker E, Oostdijk W, van der Kamp HJ, van Zwet EW, van der Hout AH, Wit JM, Losekoot M. Phenotypic characterization of patients with deletions in the 3'-flanking SHOX region. PeerJ. 2013 Feb 19;1:e35. doi: 10.7717/peerj.35. Print 2013. PMID: 23638371; PMCID: PMC3629036.
Copy Download .nbib Format: NLM
Challenges in Advanced Therapy Medicinal Product Development: A Survey among Companies in Europe.

Molecular therapy. Methods & clinical development

Ten Ham RMT, Hoekman J, Hövels AM, Broekmans AW, Leufkens HGM, Klungel OH.
PMID: 30456217
Mol Ther Methods Clin Dev. 2018 Oct 11;11:121-130. doi: 10.1016/j.omtm.2018.10.003. eCollection 2018 Dec 14.

Advanced therapy medicinal products (ATMPs) hold promise as treatments for previously untreatable and high-burden diseases. Expectations are high and active company pipelines are observed, yet only 10 market authorizations were approved in Europe. Our aim was to identify challenges...

Cite
Ten Ham RMT, Hoekman J, Hövels AM, et al. Challenges in Advanced Therapy Medicinal Product Development: A Survey among Companies in Europe. Mol Ther Methods Clin Dev. 2018;11:121-130doi: 10.1016/j.omtm.2018.10.003.
Ten Ham, R. M. T., Hoekman, J., Hövels, A. M., Broekmans, A. W., Leufkens, H. G. M., & Klungel, O. H. (2018). Challenges in Advanced Therapy Medicinal Product Development: A Survey among Companies in Europe. Molecular therapy. Methods & clinical development, 11121-130. https://doi.org/10.1016/j.omtm.2018.10.003
Ten Ham, Renske M T, et al. "Challenges in Advanced Therapy Medicinal Product Development: A Survey among Companies in Europe." Molecular therapy. Methods & clinical development vol. 11 (2018): 121-130. doi: https://doi.org/10.1016/j.omtm.2018.10.003
Ten Ham RMT, Hoekman J, Hövels AM, Broekmans AW, Leufkens HGM, Klungel OH. Challenges in Advanced Therapy Medicinal Product Development: A Survey among Companies in Europe. Mol Ther Methods Clin Dev. 2018 Oct 11;11:121-130. doi: 10.1016/j.omtm.2018.10.003. eCollection 2018 Dec 14. PMID: 30456217; PMCID: PMC6234262.
Copy Download .nbib Format: NLM
Corrigendum to 'Hysteroscopy prior to a first IVF treatment cycle: the need for well-performed RCT' [Reproductive BioMedicine Online 29 (2014) 142-142].

Reproductive biomedicine online

Smit JG, Torrance HL, Broekmans FJ, Mol BW.
PMID: 28314652
Reprod Biomed Online. 2017 May;34(5):486. doi: 10.1016/j.rbmo.2017.02.007. Epub 2017 Mar 14.

No abstract available.

Cite
Smit JG, Torrance HL, Broekmans FJ, et al. Corrigendum to 'Hysteroscopy prior to a first IVF treatment cycle: the need for well-performed RCT' [Reproductive BioMedicine Online 29 (2014) 142-142]. Reprod Biomed Online. 2017;34(5):486doi: 10.1016/j.rbmo.2017.02.007.
Smit, J. G., Torrance, H. L., Broekmans, F. J., & Mol, B. W. (2017). Corrigendum to 'Hysteroscopy prior to a first IVF treatment cycle: the need for well-performed RCT' [Reproductive BioMedicine Online 29 (2014) 142-142]. Reproductive biomedicine online, 34(5), 486. https://doi.org/10.1016/j.rbmo.2017.02.007
Smit, Janine G, et al. "Corrigendum to 'Hysteroscopy prior to a first IVF treatment cycle: the need for well-performed RCT' [Reproductive BioMedicine Online 29 (2014) 142-142]." Reproductive biomedicine online vol. 34,5 (2017): 486. doi: https://doi.org/10.1016/j.rbmo.2017.02.007
Smit JG, Torrance HL, Broekmans FJ, Mol BW. Corrigendum to 'Hysteroscopy prior to a first IVF treatment cycle: the need for well-performed RCT' [Reproductive BioMedicine Online 29 (2014) 142-142]. Reprod Biomed Online. 2017 May;34(5):486. doi: 10.1016/j.rbmo.2017.02.007. Epub 2017 Mar 14. PMID: 28314652.
Copy Download .nbib Format: NLM
Role of AMH in Prediction of Menopause.

Frontiers in endocrinology

de Kat AC, Broekmans FJM, Lambalk CB.
PMID: 34594304
Front Endocrinol (Lausanne). 2021 Sep 14;12:733731. doi: 10.3389/fendo.2021.733731. eCollection 2021.

Anti-Müllerian Hormone (AMH) is produced by small antral follicles and has evolved over the past three decades as an assumed potential marker of the number of follicles in the human ovaries, also known as ovarian reserve. This quantitative measure,...

Cite
de Kat AC, Broekmans FJM, Lambalk CB. Role of AMH in Prediction of Menopause. Front Endocrinol (Lausanne). 2021;12:733731doi: 10.3389/fendo.2021.733731.
de Kat, A. C., Broekmans, F. J. M., & Lambalk, C. B. (2021). Role of AMH in Prediction of Menopause. Frontiers in endocrinology, 12733731. https://doi.org/10.3389/fendo.2021.733731
de Kat, Annelien C, et al. "Role of AMH in Prediction of Menopause." Frontiers in endocrinology vol. 12 (2021): 733731. doi: https://doi.org/10.3389/fendo.2021.733731
de Kat AC, Broekmans FJM, Lambalk CB. Role of AMH in Prediction of Menopause. Front Endocrinol (Lausanne). 2021 Sep 14;12:733731. doi: 10.3389/fendo.2021.733731. eCollection 2021. PMID: 34594304; PMCID: PMC8476919.
Copy Download .nbib Format: NLM
[Reduction of patient discomfort, risks and costs, but not pregnancies, by a mild strategy for in-vitro fertilisation].

Nederlands tijdschrift voor geneeskunde

Heijnen EM, Eijkemans MJ, de Klerk C, Polinder S, Beckers NG, Klinkert ER, Broekmans FJ, Passchier J, te Velde ER, Macklon NS, Fauser BC.
PMID: 18491824
Ned Tijdschr Geneeskd. 2008 Apr 05;152(14):809-16.

OBJECTIVE: To compare a so-called mild in-vitro fertilisation (IVF) treatment strategy with the standard IVF treatment on the following aspects: the chance of a pregnancy resulting in full-term live birth within 1 year, patient discomfort, multiple pregnancies, and costs.DESIGN:...

Cite
Heijnen EM, Eijkemans MJ, de Klerk C, et al. Minder risico's, patiëntenongemak en kosten, maar niet minder zwangerschappen in de milde behandelstrategie voor ivf. [Reduction of patient discomfort, risks and costs, but not pregnancies, by a mild strategy for in-vitro fertilisation]. Ned Tijdschr Geneeskd. 2008;152(14):809-16
Heijnen, E. M., Eijkemans, M. J., de Klerk, C., Polinder, S., Beckers, N. G., Klinkert, E. R., Broekmans, F. J., Passchier, J., te Velde, E. R., Macklon, N. S., & Fauser, B. C. (2008). Minder risico's, patiëntenongemak en kosten, maar niet minder zwangerschappen in de milde behandelstrategie voor ivf. [Reduction of patient discomfort, risks and costs, but not pregnancies, by a mild strategy for in-vitro fertilisation]. Nederlands tijdschrift voor geneeskunde, 152(14), 809-16.
Heijnen, E M E W, et al. "Minder risico's, patiëntenongemak en kosten, maar niet minder zwangerschappen in de milde behandelstrategie voor ivf." [Reduction of patient discomfort, risks and costs, but not pregnancies, by a mild strategy for in-vitro fertilisation]. Nederlands tijdschrift voor geneeskunde vol. 152,14 (2008): 809-16.
Heijnen EM, Eijkemans MJ, de Klerk C, Polinder S, Beckers NG, Klinkert ER, Broekmans FJ, Passchier J, te Velde ER, Macklon NS, Fauser BC. Minder risico's, patiëntenongemak en kosten, maar niet minder zwangerschappen in de milde behandelstrategie voor ivf. [Reduction of patient discomfort, risks and costs, but not pregnancies, by a mild strategy for in-vitro fertilisation]. Ned Tijdschr Geneeskd. 2008 Apr 05;152(14):809-16. Dutch. PMID: 18491824.
Copy Download .nbib Format: NLM
Role of AMH in Prediction of Menopause.

Frontiers in endocrinology

de Kat AC, Broekmans FJM, Lambalk CB.
PMID: 34594304
Front Endocrinol (Lausanne). 2021 Sep 14;12:733731. doi: 10.3389/fendo.2021.733731. eCollection 2021.

Anti-Müllerian Hormone (AMH) is produced by small antral follicles and has evolved over the past three decades as an assumed potential marker of the number of follicles in the human ovaries, also known as ovarian reserve. This quantitative measure,...

Cite
de Kat AC, Broekmans FJM, Lambalk CB. Role of AMH in Prediction of Menopause. Front Endocrinol (Lausanne). 2021;12:733731doi: 10.3389/fendo.2021.733731.
de Kat, A. C., Broekmans, F. J. M., & Lambalk, C. B. (2021). Role of AMH in Prediction of Menopause. Frontiers in endocrinology, 12733731. https://doi.org/10.3389/fendo.2021.733731
de Kat, Annelien C, et al. "Role of AMH in Prediction of Menopause." Frontiers in endocrinology vol. 12 (2021): 733731. doi: https://doi.org/10.3389/fendo.2021.733731
de Kat AC, Broekmans FJM, Lambalk CB. Role of AMH in Prediction of Menopause. Front Endocrinol (Lausanne). 2021 Sep 14;12:733731. doi: 10.3389/fendo.2021.733731. eCollection 2021. PMID: 34594304; PMCID: PMC8476919.
Copy Download .nbib Format: NLM
Testing for Ovarian Reserve in Assisted Reproduction programs: the current point of view.

Facts, views & vision in ObGyn

Broekmans FJ.
PMID: 25478073
Facts Views Vis Obgyn. 2009;1(2):79-87.

Age related fertility decline varies considerably among women. Therefore, chronological female age, though informative on pregnancy prospects in assisted reproduction, will often not correctly express a woman's reproductive potential. The value of quantitative ovarian reserve tests prior to IVF/ICSI...

Cite
Broekmans FJ. Testing for Ovarian Reserve in Assisted Reproduction programs: the current point of view. Facts Views Vis Obgyn. 2009;1(2):79-87
Broekmans, F. J. (2009). Testing for Ovarian Reserve in Assisted Reproduction programs: the current point of view. Facts, views & vision in ObGyn, 1(2), 79-87.
Broekmans, F J. "Testing for Ovarian Reserve in Assisted Reproduction programs: the current point of view." Facts, views & vision in ObGyn vol. 1,2 (2009): 79-87.
Broekmans FJ. Testing for Ovarian Reserve in Assisted Reproduction programs: the current point of view. Facts Views Vis Obgyn. 2009;1(2):79-87. PMID: 25478073; PMCID: PMC4251274.
Copy Download .nbib Format: NLM
T-cell redirecting bispecific antibodies targeting BCMA for the treatment of multiple myeloma.

Oncotarget

Verkleij CPM, Frerichs KA, Broekmans M, Absalah S, Maas-Bosman PWC, Kruyswijk S, Nijhof IS, Mutis T, Zweegman S, van de Donk NWCJ.
PMID: 33227097
Oncotarget. 2020 Nov 10;11(45):4076-4081. doi: 10.18632/oncotarget.27792. eCollection 2020 Nov 10.

B-cell maturation antigen (BCMA)-targeting bispecific antibodies and bispecific T-cell engagers (BiTEs) redirect T-cells to BCMA-expressing multiple myeloma (MM) cells. These MM cells are subsequently eliminated via various mechanisms of action including the release of granzymes and perforins. Several phase...

Cite
Verkleij CPM, Frerichs KA, Broekmans M, et al. T-cell redirecting bispecific antibodies targeting BCMA for the treatment of multiple myeloma. Oncotarget. 2020;11(45):4076-4081doi: 10.18632/oncotarget.27792.
Verkleij, C. P. M., Frerichs, K. A., Broekmans, M., Absalah, S., Maas-Bosman, P. W. C., Kruyswijk, S., Nijhof, I. S., Mutis, T., Zweegman, S., & van de Donk, N. W. C. J. (2020). T-cell redirecting bispecific antibodies targeting BCMA for the treatment of multiple myeloma. Oncotarget, 11(45), 4076-4081. https://doi.org/10.18632/oncotarget.27792
Verkleij, Christie P M, et al. "T-cell redirecting bispecific antibodies targeting BCMA for the treatment of multiple myeloma." Oncotarget vol. 11,45 (2020): 4076-4081. doi: https://doi.org/10.18632/oncotarget.27792
Verkleij CPM, Frerichs KA, Broekmans M, Absalah S, Maas-Bosman PWC, Kruyswijk S, Nijhof IS, Mutis T, Zweegman S, van de Donk NWCJ. T-cell redirecting bispecific antibodies targeting BCMA for the treatment of multiple myeloma. Oncotarget. 2020 Nov 10;11(45):4076-4081. doi: 10.18632/oncotarget.27792. eCollection 2020 Nov 10. PMID: 33227097; PMCID: PMC7665238.
Copy Download .nbib Format: NLM
Endometrial scratching prior to IVF; does it help and for whom? A systematic review and meta-analysis.

Human reproduction open

van Hoogenhuijze NE, Kasius JC, Broekmans FJM, Bosteels J, Torrance HL.
PMID: 30895265
Hum Reprod Open. 2019 Jan 29;2019(1):hoy025. doi: 10.1093/hropen/hoy025. eCollection 2019.

STUDY QUESTION: What is the effect of endometrial scratching in patients with or without prior failed ART cycles on live birth (LBR) and clinical pregnancy rates (CPR)?SUMMARY ANSWER: It remains unclear if endometrial scratching improves the chance of pregnancy...

Cite
van Hoogenhuijze NE, Kasius JC, Broekmans FJM, et al. Endometrial scratching prior to IVF; does it help and for whom? A systematic review and meta-analysis. Hum Reprod Open. 2019;2019(1):hoy025doi: 10.1093/hropen/hoy025.
van Hoogenhuijze, N. E., Kasius, J. C., Broekmans, F. J. M., Bosteels, J., & Torrance, H. L. (2019). Endometrial scratching prior to IVF; does it help and for whom? A systematic review and meta-analysis. Human reproduction open, 2019(1), hoy025. https://doi.org/10.1093/hropen/hoy025
van Hoogenhuijze, N E, et al. "Endometrial scratching prior to IVF; does it help and for whom? A systematic review and meta-analysis." Human reproduction open vol. 2019,1 (2019): hoy025. doi: https://doi.org/10.1093/hropen/hoy025
van Hoogenhuijze NE, Kasius JC, Broekmans FJM, Bosteels J, Torrance HL. Endometrial scratching prior to IVF; does it help and for whom? A systematic review and meta-analysis. Hum Reprod Open. 2019 Jan 29;2019(1):hoy025. doi: 10.1093/hropen/hoy025. eCollection 2019. PMID: 30895265; PMCID: PMC6396643.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 43 entries